Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,655 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
As investors eye Regal Rexnord’s Q1 2026 earnings, the focus turns to demand momentum, margin discipline, and capital...
A wave of consolidation in homebuilding is driven by scale and access to the foreign capital market, reshaping how de...
A cybersecurity-focused ETF bearing the infamous ticker SPAM is delivering strong 2026 gains, tripling the S&P 500's ...
The bwlp 2025 earnings call is a pivotal moment for BW LPG investors. This article breaks down what to expect, how to...
A 73-year-old retiree with $1.6 million faces a long, uncertain horizon. New modeling suggests an 80/20 bond-heavy pl...
A retiree inherits a traditional IRA and sees Medicare premiums rise in 2026 due to a 2024 income spike, exposing the...
A 73-year-old retiree with a $2.5 million 401(K) just began required minimum distributions, triggering a tax bill tha...
Two real estate ETFs take opposite paths: one spreads bets worldwide, the other bets on the U.S. market. Learn how HA...
Hitting 62 with $800,000 saved feels like a milestone. But financial risk remains as you plot decades of retirement. ...
Two ETFs that use option strategies are paying monthly distributions that exceed traditional dividend bets, signaling...
Standard Chartered challenges the de-dollarization narrative, arguing that global focus remains on the U.S. dollar as...